{"id":"55a81e13-fb85-4bd8-8951-c16d2bd50eff","name":"Vitestro","slug":"vitestro","description":"Dutch medical-robotics company; maker of Aletta, billed as the World's first autonomous robotic phlebotomy device, combining AI, ultrasound imaging, and robotics to locate veins and draw blood, with ~94.5% first-stick success and EU MDR approval. Private.","status":"private","founded":null,"hq":"Nieuwegein, Netherlands","hqLat":52.0298704,"hqLng":5.0929334,"hqGeocodedAt":"2026-08-05T14:54:00.053Z","hqAddress":null,"hqPrecision":null,"website":"vitestro.com","fundingTotal":"70000000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://vitestro.com/aletta/","title":"Vitestro Aletta phlebotomy robot"},{"url":"https://vitestro.com/news/vitestro-receives-fda-de-novo-authorization-for-aletta/","title":"Vitestro Receives FDA De Novo Authorization for Aletta","sourceName":"Vitestro"},{"url":"https://www.instagram.com/reel/Dd4S8z6gytB/","title":"Vitestro Aletta drawing blood from real patients; NIR/ultrasound/Doppler (uncover.robotics via Instagram)","sourceName":"Instagram (@uncover.robotics / via Deploy.Report digest)","publishedAt":"2026-09-29"}],"keyFacts":[{"label":"Aletta","value":"An autonomous robotic phlebotomy device (ARPD), the company's medical robotics product."},{"label":"Technology (company-claimed)","value":"Combines near-infrared, ultrasound and Doppler ultrasound imaging with robotics and AI to locate veins, guide needle insertion and collect blood samples."},{"label":"First-stick success rate","value":"About 94.5%."},{"label":"Europe (company-claimed)","value":"Aug 2026: CE-marked under EU MDR and in clinical and pre-commercial use in Europe, where commercial deployment comes first."},{"label":"FDA De Novo (company-claimed)","value":"Aug 2026: The FDA granted De Novo authorization, a new device classification; Vitestro calls it the first US clearance for a fully autonomous blood draw system."},{"label":"US plans (company-claimed)","value":"Aug 2026: Plans a US multicenter clinical trial before US commercial availability."}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-24T05:33:59.935Z","updatedAt":"2026-10-21T00:48:47.997Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/vitestro","url":"https://registry.deploy.report/companies/vitestro","name":"Vitestro","description":"Dutch medical-robotics company; maker of Aletta, billed as the World's first autonomous robotic phlebotomy device, combining AI, ultrasound imaging, and robotics to locate veins and draw blood, with ~94.5% first-stick success and EU MDR approval. Private.","identifier":"55a81e13-fb85-4bd8-8951-c16d2bd50eff","address":"Nieuwegein, Netherlands","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":3,"primary_source_types":[]}}}